OVAMEX sol inj 0.25 mg/0.5ml ser pré

7680687920018 CH-68792 H01CC01 07.09.0.
OVAMEX sol inj 0.25 mg/0.5ml ser pré
OVAMEX sol inj 0.25 mg/0.5ml ser pré
OVAMEX sol inj 0.25 mg/0.5ml ser pré
1 / 3
google

Details

Product number
6879201
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
ganirelixum 0.25 mg ut ganirelixi acetas, acidum aceticum glaciale, mannitolum, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp., natrium 0.023 mg.

Articles (1)

Ovamex, Injektionslösung in einer Fertigspritze
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/03/2024
Patient information leaflet
Français
05/03/2024
Patient information leaflet
Italien
05/03/2024
Professional SmPC
Allemand
05/03/2024
Professional SmPC
Français
05/03/2024
Professional SmPC
Italien
05/03/2024

Detailed composition

Substance Quantity Type Category
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.023 MG Substance HBESI

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
68792
Drug name
Ovamex, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
H01CC01
Authorization status
Z
Dispensation category
A
First authorization
06/02/2023
Authorization expiration date
05/02/2028
IT number
07.09.0.
Domain
Human medicine
Field of application
Assistierte Reproduktionsmedizin

Packaging details

Description (FR)
OVAMEX sol inj 0.25 mg/0.5ml ser pré
Description (DE)
OVAMEX Inj Lös 0.25 mg/0.5ml Fertspr
Market launch
06/02/2023
Narcotic (BTM)
No

Other packaging sizes